
Johnson & Johnson (JNJ) Financial Statements
Price: $163.29
Market Cap: $393.50B
Avg Volume: 9.02M
Market Cap: $393.50B
Avg Volume: 9.02M
Country: US
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Johnson & Johnson.
Income Statement
Breakdown | December 29, 2024 | December 31, 2023 | January 01, 2023 | January 02, 2022 | January 03, 2021 | December 29, 2019 | December 30, 2018 | December 31, 2017 | January 01, 2017 | January 03, 2016 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | $88.82B | $85.16B | $79.99B | $78.74B | $82.58B | $82.06B | $81.58B | $76.45B | $71.89B | $70.07B |
Cost of Revenue | $27.47B | $26.55B | $24.60B | $23.40B | $28.43B | $27.56B | $27.09B | $25.44B | $21.79B | $21.54B |
Gross Profit | $61.35B | $58.61B | $55.39B | $55.34B | $54.16B | $54.50B | $54.49B | $51.01B | $50.10B | $48.54B |
Gross Profit Ratio | 69.10% | 68.80% | 69.25% | 70.30% | 65.58% | 66.42% | 66.79% | 66.84% | 69.84% | 69.27% |
Research and Development Expenses | $17.23B | $15.09B | $14.13B | $14.28B | $12.34B | $11.36B | $10.78B | $10.59B | $9.14B | $9.05B |
General and Administrative Expenses | $21.97B | $20.11B | $20.25B | $20.12B | $22.08B | $22.18B | $22.54B | $21.52B | $20.07B | $21.20B |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $21.97B | $20.11B | $20.25B | $20.12B | $22.08B | $22.18B | $22.54B | $21.52B | $20.07B | $21.20B |
Other Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Operating Expenses | $39.20B | $35.20B | $34.38B | $34.40B | $34.42B | $33.53B | $33.31B | $32.11B | $29.21B | $30.25B |
Cost and Expenses | $66.67B | $61.75B | $58.98B | $57.80B | $62.85B | $61.09B | $60.41B | $57.55B | $51.00B | $51.78B |
Interest Income | $1.33B | $1.26B | $490.00M | $53.00M | $111.00M | $357.00M | $611.00M | $385.00M | $368.00M | $128.00M |
Interest Expense | $755.00M | $772.00M | $276.00M | $183.00M | $201.00M | $318.00M | $1.00B | $934.00M | $726.00M | $552.00M |
Depreciation and Amortization | $7.34B | $7.49B | $6.97B | $7.39B | $7.23B | $7.01B | $6.93B | $5.64B | $3.75B | $3.75B |
EBITDA | $24.78B | $23.32B | $26.61B | $26.75B | $23.93B | $24.66B | $25.93B | $24.25B | $24.28B | $23.49B |
EBITDA Ratio | 40.39% | 27.86% | 37.71% | 35.38% | 29.27% | 26.96% | 27.64% | 25.95% | 30.16% | 27.15% |
Operating Income | $22.15B | $23.41B | $21.01B | $20.94B | $19.73B | $20.97B | $21.18B | $18.90B | $20.89B | $18.29B |
Operating Income Ratio | 22.93% | 27.49% | 28.99% | 26.00% | 20.52% | 18.42% | 19.15% | 18.57% | 24.94% | 21.80% |
Total Other Income Expenses Net | $-5.46B | $-8.35B | $-1.65B | $-1.76B | $-3.24B | $-3.64B | $-3.18B | $-1.22B | $-1.09B | $907.00M |
Income Before Tax | $16.69B | $15.06B | $19.36B | $19.18B | $16.50B | $17.33B | $18.00B | $17.67B | $19.80B | $19.20B |
Income Before Tax Ratio | 27.20% | 17.69% | 24.20% | 24.36% | 19.98% | 21.12% | 22.06% | 23.12% | 27.55% | 27.39% |
Income Tax Expense | $2.62B | $1.74B | $2.99B | $1.38B | $1.78B | $2.21B | $2.70B | $16.37B | $3.26B | $3.79B |
Net Income | $14.07B | $35.15B | $17.94B | $20.88B | $14.71B | $15.12B | $15.30B | $1.30B | $16.54B | $15.41B |
Net Income Ratio | 22.93% | 41.28% | 22.43% | 26.52% | 17.82% | 18.42% | 18.75% | 1.70% | 23.01% | 21.99% |
EPS | $5.84 | $13.88 | $6.83 | $7.93 | $5.59 | $5.74 | $5.75 | $0.48 | $6.08 | $5.57 |
EPS Diluted | $5.79 | $13.72 | $6.73 | $7.81 | $5.51 | $5.63 | $5.61 | $0.47 | $5.93 | $5.48 |
Weighted Average Shares Outstanding | 2.41B | 2.53B | 2.61B | 2.63B | 2.63B | 2.63B | 2.66B | 2.68B | 2.71B | 2.76B |
Weighted Average Shares Outstanding Diluted | 2.43B | 2.56B | 2.66B | 2.67B | 2.67B | 2.68B | 2.73B | 2.75B | 2.79B | 2.81B |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 29, 2024 | December 31, 2023 | January 01, 2023 | January 02, 2022 | January 03, 2021 | December 29, 2019 | December 30, 2018 | December 31, 2017 | January 01, 2017 | January 03, 2016 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $24.11B | $21.86B | $12.89B | $14.49B | $13.98B | $17.30B | $18.11B | $17.82B | $18.97B | $13.73B |
Short Term Investments | $417.00M | $1.07B | $9.39B | $17.12B | $11.20B | $1.98B | $1.58B | $472.00M | $22.93B | $24.64B |
Cash and Short Term Investments | $24.52B | $22.93B | $22.28B | $31.61B | $25.18B | $19.29B | $19.69B | $18.30B | $41.91B | $38.38B |
Net Receivables | $18.93B | $14.87B | $14.04B | $15.28B | $13.58B | $14.48B | $14.10B | $13.49B | $11.70B | $10.73B |
Inventory | $12.44B | $11.18B | $10.27B | $10.39B | $9.34B | $9.02B | $8.60B | $8.77B | $8.14B | $8.05B |
Other Current Assets | $- | $4.51B | $8.71B | $3.70B | $3.13B | $2.49B | $3.65B | $2.54B | $3.28B | $3.05B |
Total Current Assets | $55.89B | $53.49B | $55.29B | $60.98B | $51.24B | $45.27B | $46.03B | $43.09B | $65.03B | $60.21B |
Property Plant Equipment Net | $21.62B | $19.90B | $17.98B | $18.96B | $18.77B | $17.66B | $17.04B | $17.00B | $15.91B | $15.90B |
Goodwill | $44.20B | $36.56B | $36.05B | $35.25B | $36.39B | $33.64B | $30.45B | $31.91B | $22.80B | $21.63B |
Intangible Assets | $37.62B | $34.17B | $38.49B | $46.39B | $53.40B | $47.64B | $47.61B | $53.23B | $26.88B | $25.76B |
Goodwill and Intangible Assets | $81.82B | $70.73B | $74.54B | $81.64B | $89.80B | $81.28B | $78.06B | $85.13B | $49.68B | $47.39B |
Long Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Tax Assets | $- | $9.28B | $8.95B | $10.22B | $8.53B | $7.82B | $7.64B | $7.11B | $6.15B | $5.49B |
Other Non-Current Assets | $20.77B | $14.15B | $30.62B | $10.22B | $6.56B | $5.70B | $4.18B | $4.97B | $4.43B | $4.41B |
Total Non-Current Assets | $124.21B | $114.06B | $132.08B | $121.04B | $123.66B | $112.45B | $106.92B | $114.22B | $76.18B | $73.20B |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $180.10B | $167.56B | $187.38B | $182.02B | $174.89B | $157.73B | $152.95B | $157.30B | $141.21B | $133.41B |
Account Payables | $10.31B | $9.63B | $9.89B | $11.05B | $9.51B | $8.54B | $7.54B | $7.31B | $6.92B | $6.67B |
Short Term Debt | $5.98B | $3.45B | $12.76B | $3.77B | $2.63B | $1.20B | $2.80B | $3.91B | $4.68B | $7.00B |
Tax Payables | $3.77B | $2.99B | $2.22B | $1.11B | $1.39B | $2.27B | $818.00M | $1.85B | $971.00M | $750.00M |
Deferred Revenue | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Current Liabilities | $30.25B | $30.21B | $30.94B | $29.29B | $28.96B | $23.95B | $20.08B | $17.47B | $13.71B | $13.32B |
Total Current Liabilities | $50.32B | $46.28B | $55.80B | $45.23B | $42.49B | $35.96B | $31.23B | $30.54B | $26.29B | $27.75B |
Long Term Debt | $30.65B | $26.98B | $27.99B | $29.98B | $32.63B | $26.49B | $27.68B | $30.68B | $22.44B | $12.86B |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $2.45B | $3.19B | $3.99B | $7.49B | $7.21B | $5.96B | $7.51B | $8.37B | $2.91B | $2.56B |
Other Non-Current Liabilities | $25.19B | $22.33B | $22.80B | $25.30B | $29.27B | $29.84B | $26.78B | $27.56B | $19.15B | $19.09B |
Total Non-Current Liabilities | $58.29B | $52.50B | $54.77B | $62.77B | $69.12B | $62.29B | $61.97B | $66.61B | $44.50B | $34.51B |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $108.61B | $98.78B | $110.57B | $108.00B | $111.62B | $98.26B | $93.20B | $97.14B | $70.79B | $62.26B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B |
Retained Earnings | $- | $153.84B | $128.34B | $123.06B | $113.89B | $110.66B | $106.22B | $101.79B | $110.55B | $103.88B |
Accumulated Other Comprehensive Income Loss | $-11.74B | $-12.53B | $-12.97B | $-13.06B | $-15.24B | $-15.89B | $-15.22B | $-13.20B | $-14.90B | $-13.16B |
Other Total Stockholders Equity | $80.11B | $-75.66B | $-41.69B | $-39.10B | $-38.49B | $-38.42B | $-34.36B | $-31.55B | $-28.35B | $-22.68B |
Total Stockholders Equity | $71.49B | $68.77B | $76.80B | $74.02B | $63.28B | $59.47B | $59.75B | $60.16B | $70.42B | $71.15B |
Total Equity | $71.49B | $68.77B | $76.80B | $74.02B | $63.28B | $59.47B | $59.75B | $- | $- | $- |
Total Liabilities and Stockholders Equity | $180.10B | $167.56B | $187.38B | $182.02B | $174.89B | $157.73B | $152.95B | $157.30B | $141.21B | $133.41B |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $180.10B | $167.56B | $187.38B | $182.02B | $174.89B | $157.73B | $152.95B | $157.30B | $141.21B | $133.41B |
Total Investments | $417.00M | $1.07B | $9.39B | $17.12B | $11.20B | $1.98B | $1.58B | $472.00M | $22.93B | $24.64B |
Total Debt | $36.63B | $29.33B | $39.64B | $33.75B | $35.27B | $27.70B | $30.48B | $34.58B | $27.13B | $19.86B |
Net Debt | $12.53B | $7.47B | $26.75B | $19.26B | $21.28B | $10.39B | $12.37B | $16.76B | $8.15B | $6.13B |
Cash Flow Statement
Breakdown | December 29, 2024 | December 31, 2023 | January 01, 2023 | January 02, 2022 | January 03, 2021 | December 29, 2019 | December 30, 2018 | December 31, 2017 | January 01, 2017 | January 03, 2016 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | $14.07B | $13.33B | $17.94B | $20.88B | $14.71B | $15.12B | $15.30B | $1.30B | $16.54B | $15.41B |
Depreciation and Amortization | $7.34B | $7.49B | $6.97B | $7.39B | $7.23B | $7.01B | $6.93B | $5.64B | $3.75B | $3.75B |
Deferred Income Tax | $-2.18B | $-4.19B | $-1.66B | $-2.08B | $-1.14B | $-2.48B | $-1.02B | $2.41B | $-341.00M | $-270.00M |
Stock Based Compensation | $1.18B | $1.16B | $1.14B | $1.14B | $1.00B | $977.00M | $978.00M | $962.00M | $878.00M | $874.00M |
Change in Working Capital | $1.84B | $2.51B | $-4.01B | $-4.24B | $2.69B | $3.87B | $3.00M | $11.24B | $-1.77B | $1.34B |
Accounts Receivables | $-406.00M | $-624.00M | $-1.29B | $-2.40B | $774.00M | $-289.00M | $-1.19B | $-633.00M | $-1.06B | $-433.00M |
Inventory | $-1.13B | $-1.32B | $-2.53B | $-1.25B | $-265.00M | $-277.00M | $-644.00M | $581.00M | $-249.00M | $-449.00M |
Accounts Payables | $1.62B | $2.35B | $1.10B | $2.44B | $5.14B | $4.06B | $-12.97B | $2.73B | $-39.20B | $-30.24B |
Other Working Capital | $1.75B | $2.11B | $-1.29B | $-3.02B | $-2.96B | $371.00M | $14.80B | $11.29B | $38.74B | $32.46B |
Other Non Cash Items | $2.03B | $2.50B | $819.00M | $324.00M | $-963.00M | $-1.08B | $10.00M | $-495.00M | $-291.00M | $-1.82B |
Net Cash Provided by Operating Activities | $24.27B | $22.79B | $21.19B | $23.41B | $23.54B | $23.42B | $22.20B | $21.06B | $18.77B | $19.28B |
Investments in Property Plant and Equipment | $-4.42B | $-4.54B | $-4.01B | $-3.65B | $-3.35B | $-3.50B | $-3.67B | $-3.28B | $-3.23B | $-3.46B |
Acquisitions Net | $-15.15B | $- | $-17.65B | $-60.00M | $-7.32B | $-5.81B | $-899.00M | $-35.15B | $-4.51B | $-954.00M |
Purchases of Investments | $-1.73B | $-10.91B | $-32.38B | $-30.39B | $-21.09B | $-3.92B | $-5.63B | $-6.15B | $-33.95B | $-40.83B |
Sales Maturities of Investments | $2.46B | $19.39B | $41.61B | $25.01B | $12.14B | $3.73B | $4.29B | $28.12B | $35.78B | $34.15B |
Other Investing Activities | $235.00M | $-3.06B | $65.00M | $417.00M | $-1.20B | $3.31B | $2.74B | $1.60B | $1.14B | $3.36B |
Net Cash Used for Investing Activities | $-18.60B | $878.00M | $-12.37B | $-8.68B | $-20.82B | $-6.19B | $-3.17B | $-14.87B | $-4.76B | $-7.74B |
Debt Repayment | $10.05B | $-2.73B | $-2.13B | $-990.00M | $7.09B | $-2.88B | $-3.95B | $6.75B | $7.88B | $1.38B |
Common Stock Issued | $- | $4.24B | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Repurchased | $-2.43B | $-5.05B | $-6.04B | $-3.46B | $-3.22B | $-6.75B | $-5.87B | $-6.36B | $-8.98B | $-5.29B |
Dividends Paid | $-11.82B | $-11.77B | $-11.68B | $-11.03B | $-10.48B | $-9.92B | $-9.49B | $-8.94B | $-8.62B | $-8.17B |
Other Financing Activities | $1.07B | $-508.00M | $10.98B | $1.43B | $487.00M | $1.53B | $801.00M | $874.00M | $1.17B | $948.00M |
Net Cash Used Provided by Financing Activities | $-3.13B | $-15.82B | $-8.87B | $-14.05B | $-6.12B | $-18.02B | $-18.51B | $-7.67B | $-8.55B | $-10.85B |
Effect of Forex Changes on Cash | $-289.00M | $-112.00M | $-312.00M | $-178.00M | $89.00M | $-9.00M | $-241.00M | $337.00M | $-215.00M | $-1.49B |
Net Change in Cash | $2.25B | $7.73B | $-360.00M | $502.00M | $-3.32B | $-802.00M | $283.00M | $-1.15B | $5.24B | $-791.00M |
Cash at End of Period | $24.11B | $21.86B | $14.13B | $14.49B | $13.98B | $17.30B | $18.11B | $17.82B | $18.97B | $13.73B |
Cash at Beginning of Period | $21.86B | $14.13B | $14.49B | $13.98B | $17.30B | $18.11B | $17.82B | $18.97B | $13.73B | $14.52B |
Operating Cash Flow | $24.27B | $22.79B | $21.19B | $23.41B | $23.54B | $23.42B | $22.20B | $21.06B | $18.77B | $19.28B |
Capital Expenditure | $-4.42B | $-4.54B | $-4.01B | $-3.65B | $-3.35B | $-3.50B | $-3.67B | $-3.28B | $-3.23B | $-3.46B |
Free Cash Flow | $19.84B | $18.25B | $17.18B | $19.76B | $20.19B | $19.92B | $18.53B | $17.78B | $15.54B | $15.82B |